NWSA
89
5
ROK
51
12
TXN
55
2
PYPL
35
2
CINF
51
-6
SIG
78
-3
IR
85
3
UNM
67
-4
BLK
55
-14
XOM
54
-2
BF.B
51
-6
AVB
67
-7
CMA
46
-4
SLB
44
-2
RHI
32
-2
JPM
63
-10
BAC
53
-3
RSG
65
-3
CB
50
-5
NFLX
66
2
NWSA
89
5
ROK
51
12
TXN
55
2
PYPL
35
2
CINF
51
-6
SIG
78
-3
IR
85
3
UNM
67
-4
BLK
55
-14
XOM
54
-2
BF.B
51
-6
AVB
67
-7
CMA
46
-4
SLB
44
-2
RHI
32
-2
JPM
63
-10
BAC
53
-3
RSG
65
-3
CB
50
-5
NFLX
66
2
Financhill
Back

CVS Health Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
41

CVS
CVS Health

Last Price:
57.43
Seasonality Move:
2.86%
Sell
38

ITCI
Intra-Cellular Therapies

Last Price:
65.29
Seasonality Move:
-6.93%
Sell
41
CVS Health (CVS) is a Sell

Is CVS Health a Buy, Sell or Hold?

  • The current CVS Health [CVS] share price is $57.40. The Score for CVS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • CVS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $65.32. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CVS Stock Price Chart

What is CVS Health's stock price today?

  • The CVS Health share price today is $57.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CVS is experiencing selling pressure, which indicates risk of future bearish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $65.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight buying pressure.

CVS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.53 Sell
Relative Strength Index (14 RSI): 31.38 Sell
Chaikin Money Flow: -6468319 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.46 - 67.68) Sell
Bollinger Bands (100): (65.02 - 79.74) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.32 Sell
Relative Strength Index (14 RSI): 41.48 Sell
Chaikin Money Flow: 421582 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.45 - 74.29) Sell
Bollinger Bands (100): (65.99 - 72.19) Sell

CVS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.6 Buy
20-day SMA: 59.64 Sell
50-day SMA: 68.62 Sell
200-day SMA: 71.37 Sell
8-day EMA: 57.15 Buy
20-day EMA: 59.81 Sell
50-day EMA: 65.63 Sell
200-day EMA: 71.9 Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.78 Sell
20-day SMA: 69.19 Sell
50-day SMA: 68.67 Sell
200-day SMA: 62.8 Buy
8-day EMA: 66.34 Sell
20-day EMA: 68 Sell
50-day EMA: 68.71 Sell
200-day EMA: 64.66 Buy

CVS Health Earnings Growth & CVS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.07 per share, a decrease this year of $1.61 per share, and an increase next year of $1.04 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.

CVS Health Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):